Latham & Watkins Advises Novo Holdings on Quanta’s US$245 Million Series D Fundraising
Latham & Watkins advised Novo Holdings on co-leading a US$245 Million Series D funding round for Quanta Dialysis Technologies, a medical technology leader delivering on its vision for more flexible and accessible dialysis care.
The round was co-led by hedge fund Glenview Capital, with support from a broad group of other top-tier investors, including BlackRock, Eldridge, Sands Capital, Millennium, Monashee Investment Management LLC., Puhua Capital, Segulah Medical and Ancora, alongside Orlando Health, an integrated delivery network. Existing shareholders also participated in the round, including Wellington Partners, btov, Seroba and The Grands.
The Latham team was led by London corporate
partner Robbie McLaren, with associate Samantha Peacock.